Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04002518 · ClinicalTrials.gov registry record
MDR - Biomet Cannulated Screws
A clinical trial of Fractures, Bone and Fracture Multiple, sponsored by Zimmer Biomet.
- Active
- Registry status
- 51
- Enrollment target
- 3
- Study locations
NCT04002518: Active study of Fractures, Bone and Fracture Multiple, sponsored by Zimmer Biomet.
NCT04002518 is a study of Fractures, Bone and Fracture Multiple that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 51 participants, below the 1,941-participant average among 12 other Fractures, Bone trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04002518, a study of Fractures, Bone and Fracture Multiple, is active but no longer recruiting, sponsored by Zimmer Biomet.
- ACTIVE NOT RECRUITING
- Registry status
- 51 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objective of this retrospective enrollment/prospective follow up study is to collect data confirming safety, performance, and clinical benefits of the Biomet Cannulated Bone Screw System (Implants and Instrumentation) when used according to the approved Indications for Use (IFU).
Primary Outcome
Assessment of safety by recording and analyzing the incidence and frequency of revisions, complications, and adverse events.
Conditions Studied
Interventions
- DEVICE Biomet Cannulated Screw: 3.0, 4.0, 5.0, 6.5, and 8.0mm screws.
Study Locations (3)
Indiana
- Zimmer Biomet - Warsaw
Ohio
- Orthopedic Foot and Ankle Center - Worthington
Virginia
- Associated Foot & Ankle Centers of Northern Virginia - Lake Ridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2019-08-07 |
| Est. Completion | 2026-12 |
What the registry record for NCT04002518 still lists
NCT04002518 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,941-participant average among 12 other Fractures, Bone trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Fractures, Bone appearing as the primary indexed condition, and to 1 intervention - of which Biomet Cannulated Screw: 3.0, 4.0, 5.0, 6.5, and 8.0mm screws. is the first listed.
NCT04002518 reports a single indexed study location in Indiana, Ohio, Virginia.
Frequently Asked Questions
What is clinical trial NCT04002518 about?
NCT04002518 is a clinical study titled "MDR - Biomet Cannulated Screws". The objective of this retrospective enrollment/prospective follow up study is to collect data confirming safety, performance, and clinical benefits of the Biomet Cannulated Bone Screw System (Implants and Instrumentation) when used according to the approved Indications for Use (IFU).
What is the current status of trial NCT04002518?
This trial is currently active not recruiting. The enrollment target is 51 participants. The study started on 2019-08-07. Estimated completion is 2026-12.
What conditions does trial NCT04002518 study?
This clinical trial studies the following conditions: Fractures, Bone, Fracture Multiple.
What interventions are being tested in trial NCT04002518?
The interventions under investigation include: Biomet Cannulated Screw: 3.0, 4.0, 5.0, 6.5, and 8.0mm screws. (DEVICE).
Who is sponsoring clinical trial NCT04002518?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04002518 being conducted?
This trial has 3 study locations across Indiana, Ohio, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fractures, Bone
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04002518's enrollment target sits among peer trials
51 10th of 12 higher than 3 of 12 other Fractures, Bone trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fractures, Bone trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk
RECRUITING
-
PAINED: Project Addressing INequities in the Emergency Department
RECRUITING · NA
-
Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care
RECRUITING
-
Virtual Reality During Pediatric Cast Removal
RECRUITING · NA
-
Cast Art for Kids With Extremity Fractures
RECRUITING · NA
-
Continuous Passive Motion Following Fixation of Pelvic and Knee Fractures
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI